Skip to main content
Log in

Pediatric glioblastoma: a single institution experience

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to evaluate characteristics of childhood glioblastoma multiforme, effectiveness of treatment modalities, and detect factors related to outcome.

Methods

A detailed analysis was performed on a series of 15 patients treated between 2000 and 2013, based on their clinical, radiologic, pathologic, treatment, and follow-up data.

Results

Median survival time of children with glioblastoma was 13.5 months. One- and 2-year overall survival probabilities were 66.7 and 20 %, respectively. There were no significant differences in survival based on patients’ gender, age, disease presentation with or without epileptic seizures, signs/symptoms of increased intracranial pressure, or tumor location. The presence of neurological deficit initially, as well as prior to radiotherapy, which was quantified by neurologic function score (NFS), had an impact on overall survival. Children with NFS 0 lived longer compared to others (p = 0.001). Survival of children that underwent gross total resection was longer than that of children that underwent subtotal resection (p = 0.030). Mean survival time of children with gross total resection was 73.5 months, compared to 13 months in children with subtotal resection. There was no significant correlation between outcome and type of radiotherapy. In four patients with gigantocellular glioblastoma, we found no evidence of a better prognosis. Two long-term survivors were recorded. Both of them underwent gross total resection and were assigned a NFS 0.

Conclusions

Gross total resection is essential for longer overall survival among pediatric patients with glioblastoma and offers a possibility for long-term survival. Severity of neurologic symptoms quantified by NFS can be considered as a potential predictor of outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol 14(suppl 5):1–57. doi:10.1093/neuonc/nou223

    Article  Google Scholar 

  2. Mahvash M, Hugo H-H, Maslehaty H, Mehdorn HM, Stark AM (2011) Glioblastoma multiforme in children: report of 13 cases and review of the literature. Pediatr Neurol 45:178–180. doi:10.1016/j.pediatrneurol.2011.05.004

    Article  PubMed  Google Scholar 

  3. Sánchez-Herrera F, Castro-Sierra E, Gordillo-Domínguez LF et al (2009) Glioblastoma multiforme in children: experience at Hospital Infantil de Mexico Federico Gomez. Childs Nerv Syst 25:551–557. doi:10.1007/s00381-008-0780-8

    Article  PubMed  Google Scholar 

  4. Das KK, Mehrotra A, Nair AP et al (2012) Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome. Childs Nerv Syst 28:2055–2062. doi:10.1007/s00381-012-1890-x

    Article  PubMed  Google Scholar 

  5. Perkins SM, Rubin JB, Leonard JR et al (2011) Glioblastoma in children: a single-institution experience. Int J Radiat Oncol Biol Phys 80:1117–1121. doi:10.1016/j.ijrobp.2010.03.013

    Article  PubMed  Google Scholar 

  6. Song KS, Phi JH, Cho B-K et al (2010) Long-term outcomes in children with glioblastoma. J Neurosurg Pediatr 6:145–149. doi:10.3171/2010.5.PEDS09558

    Article  PubMed  Google Scholar 

  7. MacDonald TJ, Aguilera D, Kramm CM (2011) Treatment of high-grade glioma in children and adolescents. Neuro Oncol 13:1049–58. doi:10.1093/neuonc/nor092

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Yang T, Temkin N, Barber J et al (2013) Gross total resection correlates with long-term survival in pediatric patients with glioblastoma. World Neurosurg 79:537–544. doi:10.1016/j.wneu.2012.09.015

    Article  PubMed  Google Scholar 

  9. Karremann M, Butenhoff S, Rausche U, Pietsch T, Wolff JE, Kramm CM (2009) Pediatric giant cell glioblastoma: new insights into a rare tumor entity. Neuro Oncol 11:323–329. doi:10.1215/15228517-2008-099

    Article  PubMed Central  PubMed  Google Scholar 

  10. Nikitović M, Bokun J, Paripović L, Golubičić I, Grujičić D, Sopta J (2013) Bone metastases in medulloblastoma—single institution experience. Pediatr Hematol Oncol 30:80–91. doi:10.3109/08880018.2012.752888

    Article  PubMed  Google Scholar 

  11. Nikitović M, Golubičić I, Pekmezović T, Grujičić D, Plešinac-Karapandžić V (2011) Outcome of childhood brain tumors in Serbia. J BUON 16:290–296

    PubMed  Google Scholar 

  12. Wolff JE, Gnekow AK, Kortmann RD, Pietsch T, Urban C, Graf N et al (2002) Preradiation chemotherapy for pediatric patients with high-grade glioma. Cancer 94:264–71. doi:10.1002/cncr.10114

    Article  CAS  PubMed  Google Scholar 

  13. Suri V, Das P, Pathak P et al (2009) Pediatric glioblastomas: a histopathological and molecular genetic study. Neuro Oncol 11:274–280. doi:10.1215/15228517-2008-092

    Article  PubMed Central  PubMed  Google Scholar 

  14. Reddy GD, Sen AN, Patel AJ, Bollo RJ, Jea A (2013) Glioblastoma of the cerebellum in children: report of five cases and review of the literature. Childs Nerv Syst 29:821–832. doi:10.1007/s00381-012-1996-1

    Article  PubMed  Google Scholar 

  15. Vern-Gross TZ, Broniscer A, Schreiber J, Xiong X, Merchant TE (2012) Prospective evaluation of local control and late effects of image guided radiation therapy in childhood high-grade glioma. Int J Radiat Oncol Biol Phys 84:S67. doi:10.1093/neuonc/nou101

    Article  Google Scholar 

  16. Jung TY, Kim CY, Kim DS et al (2012) Prognosis of pediatric high-grade gliomas with temozolomide treatment: a retrospective, multicenter study. Childs Nerv Syst 28:1033–1039. doi:10.1007/s00381-012-1786-9

    Article  PubMed  Google Scholar 

  17. Duffner PK, Horowitz ME, Krischer JP et al (1999) The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience. Neuro Oncol 1:152–161

    CAS  PubMed Central  PubMed  Google Scholar 

  18. Broniscer A, Chintagumpala M, Fouladi M et al (2006) Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children. J Neurooncol 76:313–319. doi:10.1007/s11060-005-7409-5

    Article  PubMed  Google Scholar 

  19. Lashford LS, Thiesse P, Jouvet A et al (2002) Temozolomide in malignant gliomas of childhood: a United Kingdom Children’s Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol 20:4684–4691

    Article  CAS  PubMed  Google Scholar 

  20. Finlay JL, Boyett JM, Yates AJ et al (1995) Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Children’s Cancer Group. J Clin Oncol 13:112–123

    CAS  PubMed  Google Scholar 

  21. Cage TA, Mueller S, Haas-Kogan D, Gupta N (2012) High-grade gliomas in children. Neurosurg Clin N Am 23:515–23. doi:10.1016/j.nec.2012.04.007

    Article  PubMed  Google Scholar 

  22. Sabel M, Reifenberger J, Weber RG, Reifenberger G, Schmitt HP (2001) Long-term survival of a patient with giant cell glioblastoma. Case report. J Neurosurg 94:605–611. doi:10.1159/000228545

    Article  CAS  PubMed  Google Scholar 

  23. Deb P, Sharma MC, Chander B, Mahapatra AK, Sarkar C (2006) Giant cell glioblastoma multiforme: report of a case with prolonged survival and transformation to gliosarcoma. Childs Nerv Syst 22:314–319. doi:10.1007/s00381-005-1239-9

    Article  PubMed  Google Scholar 

  24. Prada I, Cordobés F, Azorín D, Contra T, Colmenero I, Glez-Mediero I (2006) Pediatric giant cell glioblastoma: a case report and review of the literature. Childs Nerv Syst 22:285–289. doi:10.1007/s00381-005-1178-5

    Article  PubMed  Google Scholar 

  25. Durno CA, Sherman PM, Aronson M, Malkin D, Hawkins C, Bakry D et al (2015) Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndrome. Eur J Cancer 51:977–983

    Article  CAS  PubMed  Google Scholar 

  26. Jain S, Sharma V, Sinha V, Sundar V, Bhasme V, Goel R (2012) Giant cell glioblastoma in a child: a rare case report. Asian J Neurosurg 7:144. doi:10.4103/1793-5482.103723

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Khalatbari MR, Hamidi M, Moharamzad Y (2011) Glioblastoma multiforme with very rapid growth and long-term survival in children: report of two cases and review of the literature. Childs Nerv Syst 27:1347–1352. doi:10.1007/s00381-011-1492-z

    Article  PubMed  Google Scholar 

  28. Sonoda Y, Kumabe T, Watanabe M et al (2009) Long-term survivors of glioblastoma: clinical features and molecular analysis. Acta Neurochir (Wien) 151:1349–1358. doi:10.1007/s00701-009-0387-1

    Article  Google Scholar 

  29. Srivastava A, Jain A, Jha P, Suri V, Sharma MC, Mallick S, Puri T, Gupta DK, Gupta A, Sarkar C (2010) MGMT gene promoter methylation in pediatric glioblastomas. Childs Nerv Syst 26:1613–8. doi:10.1007/s00381-010-1214-y

    Article  PubMed  Google Scholar 

  30. Jha P, Suri V, Singh G et al (2011) Characterization of molecular genetic alterations in GBMs highlights a distinctive molecular profile in young adults. Diagn Mol Pathol 20:225–232. doi:10.1097/PDM.0b013e31821c30bc

    Article  CAS  PubMed  Google Scholar 

  31. Sturm D, Bender S, Jones DTW et al (2014) Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat Rev Cancer 14:92–107. doi:10.1038/nrc3655

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Ezaki T, Sasaki H, Hirose Y, Miwa T, Yoshida K, Kawase T (2011) Molecular characteristics of pediatric non-ependymal, non-pilocytic gliomas associated with resistance to temozolomide. Mol Med Rep 4:1101–1105. doi:10.3892/mmr.2011.573

    CAS  PubMed  Google Scholar 

  33. Buttarelli FR, Massimino M, Antonelli M et al (2010) Evaluation status and prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in pediatric high grade gliomas. Childs Nerv Syst 26:1051–1056. doi:10.1007/s00381-010-1191-1

    Article  PubMed  Google Scholar 

  34. Lee JY, Park CK, Park SH, Wang KC, Cho BK, Kim SK (2011) MGMT promoter gene methylation in pediatric glioblastoma: analysis using MS-MLPA. Childs Nerv Syst 27:1877–1883. doi:10.1007/s00381-011-1525-7

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Ana Ivkovic, senior librarian at the Institute for Oncology and Radiology of Serbia, Belgrade, for her assistance with the preparation of this manuscript. We are also grateful to Mina Nikitovic, linguist, for her help with the linguistic aspects of this manuscript. Tatjana Pekmezovic was supported by the Ministry of Education, Science, and Technological Development of the Republic of Serbia (grant no. 175087).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marina Nikitović.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nikitović, M., Stanić, D., Pekmezović, T. et al. Pediatric glioblastoma: a single institution experience. Childs Nerv Syst 32, 97–103 (2016). https://doi.org/10.1007/s00381-015-2945-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-015-2945-6

Keywords

Navigation